Par-4-mediated recruitment of Amida to the actin cytoskeleton leads to the induction of apoptosis

Experimental Cell Research

Volumn 311, Issue 2, 2005, Pages 177-191

  Boosen, Meike ^a   Vetterkind, Susanne ^a   Koplin, Ansgar ^a   Illenberger, Susanne ^b   Preuss, Ute ^a  

^a UNIVERSITY OF BONN   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Actin cytoskeleton; Amida; Apoptosis; Par 4; Protein interaction

Indexed keywords

ACTIN; DEATH ASSOCIATED PROTEIN KINASE; LEUCINE ZIPPER PROTEIN; MYOSIN LIGHT CHAIN; PROTEIN; PROTEIN AMIDA; PROTEINASE ACTIVATED RECEPTOR 4; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; EMBRYO; FEMALE; FETUS; HETEROKARYON; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; TWO HYBRID SYSTEM; YEAST;

ANIMALIA;

EID: 27744512031     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.09.010     Document Type: Article

References (61)

1. M.D. Jacobson, M. Weil, and M.C. Raff Programmed cell death in animal development Cell 88 1997 347 354
2. P. Meier, A. Finch, and G. Evan Apoptosis in development Nature 407 2000 796 801
3. W.C. Earnshaw, L.M. Martins, and S.H. Kaufmann Mammalian caspases: structure, activation, substrates, and functions during apoptosis Annu. Rev. Biochem. 68 1999 383 424
4. J. Yuan, and B.A. Yankner Apoptosis in the nervous system Nature 407 2000 802 809
5. C. Benoist, and D. Mathis Selection for survival? Science 276 1997 2000 2001
6. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
7. F.H. Igney, and P.H. Krammer Death and anti-death: tumour resistance to apoptosis Nat. Rev., Cancer 2 2002 277 288
8. M. Zörnig, A. Hueber, W. Baum, and G. Evan Apoptosis regulators and their role in tumorigenesis Biochim. Biophys. Acta 1551 2001 1 37
9. G. Evan, and T. Littlewood A matter of life and cell death Science 281 1998 1317 1322
10. E.R. Boghaert, S.F. Sells, A.J. Walid, P. Malone, N.M. Williams, M.H. Weinstein, R. Strange, and V.M. Rangnekar Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues Cell Growth Differ. 8 1997 881 890
11. V.M. Rangnekar Apoptosis mediated by a novel leucine zipper protein Par-4 Apoptosis 3 1998 61 66
12. S.F. Sells, D.P. Wood Jr., S.S. Joshi-Barve, S. Muthukumar, R.J. Jacob, S.A. Crist, S. Humphreys, and V.M. Rangnekar Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells Cell Growth Differ. 5 1994 457 466
13. S.F. Sells, S.S. Han, S. Muthukkumar, N. Maddiwar, R. Johnstone, E. Boghaert, D. Gillis, G. Liu, P. Nair, and S. Monnig Expression and function of the leucine zipper protein Par-4 in apoptosis Mol. Cell. Biol. 17 1997 3823 3832
14. S. Bang, E.J. Jeong, I.K. Kim, Y.K. Jung, and K.S. Kim Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction J. Biol. Chem. 275 2000 36217 36222
15. C.H. Weber, and C. Vincenz The death domain superfamily: a tale of two interfaces? Trends Biochem. Sci. 26 2001 475 481
16. S. Vetterkind, S. Illenberger, J. Kubicek, M. Boosen, K.H. Scheidtmann, and U. Preuss Binding of Par-4 to the actin cytoskeleton is essential for its proapoptotic function Exp. Cell Res. 305 2005 392 408
17. G. Qiu, M. Ahmed, S.F. Sells, M. Mohiuddin, M.H. Weinstein, and V.M. Rangnekar Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4 Oncogene 18 1999 623 631
18. N. El Guendy, Y. Zhao, S. Gurumurthy, R. Burikhanov, and V.M. Rangnekar Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells Mol. Cell. Biol. 23 2003 5516 5525
19. S. Boehrer, K.U. Chow, E. Puccetti, M. Ruthardt, S. Godzisard, A. Krapohl, B. Schneider, D. Hoelzer, P.S. Mitrou, V.M. Rangnekar et al., Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia, 2 (2001) 103-107.
20. J. Cook, S. Krishnan, S. Ananth, S.F. Sells, Y. Shi, M.M. Walther, W.M. Linehan, V.P. Sukhatme, M.H. Weinstein, and V.M. Rangnekar Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma Oncogene 18 1999 1205 1208
21. T. Lucas, B. Pratscher, S. Krishnan, D. Fink, P. Gunsberg, M. Wolschek, V. Wacheck, T. Muster, I. Romirer, and K. Wolff Differential expression levels of Par-4 in melanoma Melanoma Res. 11 2001 379 383
22. M. Chakraborty, S.G. Qiu, K.M. Vasudevan, and V.M. Rangnekar Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression Cancer Res. 61 2001 7255 7263
23. S. Vetterkind, M. Boosen, K.H. Scheidtmann, and U. Preuss Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines Int. J. Oncol. 26 2005 159 167
24. M. Barradas, A. Monjas, M.T. Diaz-Meco, M. Serrano, and J. Moscat The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression EMBO J. 18 1999 6362 6369
25. S.G. Qiu, S. Krishnan, N. El Guendy, and V.M. Rangnekar Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation Oncogene 18 1999 7115 7123
26. M.T. Diaz-Meco, M.M. Municio, S. Frutos, P. Sanchez, J. Lozano, L. Sanz, and J. Moscat The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C Cell 86 1996 777 786
27. J. Moscat, and M.T. Diaz-Meco The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters EMBO Rep. 1 2000 399 403
28. M. Barkett, and T.D. Gilmore Control of apoptosis by Rel/NF-kappaB transcription factors Oncogene 18 1999 6910 6924
29. N.D. Perkins The Rel/NF-kappa B family: friend and foe Trends Biochem. Sci. 25 2000 434 440
30. B. Rayet, and C. Gelinas Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 1999 6938 6947
31. R.W. Johnstone, R.H. See, S.F. Sells, J. Wang, S. Muthukkumar, C. Englert, D.A. Haber, J.D. Licht, S.P. Sugrue, and T. Roberts A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1 Mol. Cell. Biol. 16 1996 6945 6956
32. V. Scharnhorst, A.J. van der Eb, and A.G. Jochemsen WT1 proteins: functions in growth and differentiation Gene 273 2001 141 161
33. D.J. Richard, V. Schumacher, B. Royer-Pokora, and S.G. Roberts Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1 Genes Dev. 15 2001 328 339
34. S.K. Cheema, S.K. Mishra, V.M. Rangnekar, A.M. Tari, R. Kumar, and G. Lopez-Berestein Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter J. Biol. Chem. 278 2003 19995 20005
35. S. Camandola, and M.P. Mattson Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression J. Neurosci. Res. 61 2000 134 139
36. S. Boehrer, K.U. Chow, F. Beske, N. Kukoc-Zivojnov, E. Puccetti, M. Ruthardt, C. Baum, V.M. Rangnekar, D. Hoelzer, and P.S. Mitrou In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation Cancer Res. 62 2002 1768 1775
37. M.T. Diaz-Meco, M.J. Lallena, A. Monjas, S. Frutos, and J. Moscat Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis J. Biol. Chem. 274 1999 19606 19612
38. G. Page, D. Kögel, V. Rangnekar, and K.H. Scheidtmann Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis Oncogene 18 1999 7265 7273
39. T. Kawai, M. Matsumoto, K. Takeda, H. Sanjo, and S. Akira ZIP kinase, a novel serine/threonine kinase which mediates apoptosis Mol. Cell. Biol. 18 1998 1642 1651
40. D. Kögel, O. Plöttner, G. Landsberg, S. Christian, and K.H. Scheidtmann Cloning and characterization of Dlk, a novel serine/threonine kinase that is tightly associated with chromatin and phosphorylates core histones Oncogene 17 1998 2645 2654
41. G. Shohat, G. Shani, M. Eisenstein, and A. Kimchi The DAP-kinase family of proteins: study of a novel group of calcium-regulated death-promoting kinases Biochim. Biophys. Acta 1600 2002 45 50
42. Y. Irie, K. Yamagata, Y. Gan, K. Miyamoto, E. Do, C.H. Kuo, E. Taira, and N. Miki Molecular cloning and characterization of Amida, a novel protein which interacts with a neuron-specific immediate early gene product arc, contains novel nuclear localization signals, and causes cell death in cultured cells J. Biol. Chem. 275 2000 2647 2653
43. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
44. J.M. Short, J.M. Fernandez, J.A. Sorge, and W.D. Huse Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties Nucleic Acids Res. 16 1988 7583 7600
45. E. Müller, and K.H. Scheidtmann Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53 Oncogene 10 1995 1175 1185
46. D.B. Smith, and K.S. Johnson Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase Gene 67 1988 31 40
47. S. Hüttelmaier, S. Illenberger, I. Grosheva, M. Rudiger, R.H. Singer, and B.M. Jockusch Raver1, a dual compartment protein, is a ligand for PTB/hnRNPI and microfilament attachment proteins J. Cell Biol. 155 2001 775 786
48. S. Nakielny, and G. Dreyfuss The hnRNP C proteins contain a nuclear retention sequence that can override nuclear export signals J. Cell Biol. 134 1996 1365 1373
49. G.L. Lyford, K. Yamagata, W.E. Kaufmann, C.A. Barnes, L.K. Sanders, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, A.A. Lanahan, and P.F. Worley Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton- associated protein that is enriched in neuronal dendrites Neuron 14 1995 433 445
50. S. Chang, J.H. Kim, and J. Shin p62 forms a ternary complex with PKCzeta and PAR-4 and antagonizes PAR-4-induced PKCzeta inhibition FEBS Lett. 510 2002 57 61
51. S. Pinol-Roma, and G. Dreyfuss Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm Nature 355 1992 730 732
52. Y. Gan, E. Taira, Y. Irie, T. Fujimoto, and N. Miki Arrest of cell cycle by amida which is phosphorylated by Cdc2 kinase Mol. Cell. Biochem. 246 2003 179 185
53. E. Berra, M.M. Municio, L. Sanz, S. Frutos, M.T. Diaz-Meco, and J. Moscat Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade Mol. Cell. Biol. 17 1997 4346 4354
54. M. Roussigne, C. Cayrol, T. Clouaire, F. Amalric, and J.P. Girard THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies Oncogene 22 2003 2432 2442
55. S. Boehrer, A. Brieger, S. Schaaf, N. Kukoc-Zivojnov, D. Nowak, M. Ruthardt, D. Hoelzer, P.S. Mitrou, E. Weidmann, and K.U. Chow In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis Leuk. Lymphoma 45 2004 1445 1451
56. P. Salomoni, and P.P. Pandolfi The role of PML in tumor suppression Cell 108 2002 165 170
57. J.S. Seeler, and A. Dejean The PML nuclear bodies: actors or extras? Curr. Opin. Genet. Dev. 9 1999 362 367
58. T. Kawai, S. Akira, and J.C. Reed ZIP kinase triggers apoptosis from nuclear PML oncogenic domains Mol. Cell. Biol. 23 2003 6174 6186
59. H. Suria, L.A. Chau, E. Negrou, D.J. Kelvin, and J. Madrenas Cytoskeletal disruption induces T cell apoptosis by a caspase-3 mediated mechanism Life Sci. 65 1999 2697 2707
60. D. Kulms, H. Düβmann, B. Pöppelmann, S. Ständer, A. Schwarz, and T. Schwarz Apoptosis induced by disruption of the actin cytoskeleton is mediated via activation of CD95 (Fas/APO-1) Cell Death Differ. 9 2002 598 608
61. M. Bando, Y. Miyake, M. Shiina, M. Wachi, K. Nagai, and T. Kataoka Actin cytoskeleton is required for early apoptosis signaling induced by anti-Fas antibody but not Fas ligand in murine B lymphoma A20 cells Biochem. Biophys. Res. Commun. 290 2002 268 274